[CAS NO. 666260-75-9]  GW842166X

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [666260-75-9]

Store
Catalog
SLK-S2778
Brand
Selleck
CAS
666260-75-9

DESCRIPTION [666260-75-9]

Overview

MDL-
Molecular Weight449.25
Molecular FormulaC18H17Cl2F3N4O2
SMILESC(NCC1CCOCC1)(=O)C=2C(C(F)(F)F)=NC(NC3=C(Cl)C=C(Cl)C=C3)=NC2

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2259 mL11.1297 mL22.2593 mL
5 mM0.4452 mL2.2259 mL4.4519 mL
10 mM0.2226 mL1.1130 mL2.2259 mL
50 mM---

Description

GW842166X is a potent and highly selective agonist of receptor with of 63 nM, shows no significant activity at CB1 receptor. Phase 2.

Features

Possesses selective affinity for CB2 than CB1.

Targets

CB2 [1]
63 nM(EC50)

In vitro

GW842166X shows similar potency and efficacy for rat and human recombinant CB2 receptors with EC50 of 91 nM and 63nM, respectively. GW-842166X exhibits full agonist potency with an EC50 of 133 nM and E of 101% in cyclase assays. GW-842166X exhibits weak agonist potency with an EC50 of 7.780 μM and E of 84% in FLIPR assays.

In vivo

GW842166X has an oral bioavailability of 58% and a half-life of 3 h when dosed orally in the rat. GW842166X has extremely high potency with an oral ED50 of 0.1 mg/kg and shows full reversal of hyperalgesia at 0.3 mg/kg in the FCAa model of inflammatory pain. GW842166X orally administrated at a dose of 15 mg/kg for 8 days produced a significant reversal of the CCI induced decrease in paw withdrawal threshold in a rat model of neuropathic pain.


Synonyms

5-Pyrimidinecarboxamide, 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]-4-(trifluoromethyl)-
2-[(2,4-Dichlorophenyl)amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]-4-(trifluoromethyl)-5-pyrimidinecarboxamide
2-(2,4-Dichlorophenylamino)-4-trifluoromethylpyrimidine-5-carboxylic acid [(tetrahydropyran-4-yl)methyl]amide
GW 842166X
GW 842166
2-(2,4-Dichloroanilino)-N-(oxan-4-ylmethyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide